Qube Research & Technologies LTD Applied Molecular Transport Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.16 - $0.34 $336 - $715	2,104 New	2,104 $0
Q3 2022 Nov 14, 2022	SELL	$1.12 - $3.12 $1,445 - $4,027	-1,291 Reduced 5.65%	21,567 $21,000
Q2 2022 Aug 15, 2022	BUY	$2.76 - $7.65 $63,088 - $174,863	22,858 New	22,858 $67,000
Q1 2022 May 09, 2022	SELL	$5.63 - $13.88 $144,769 - $356,910	-25,714 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$13.23 - $26.05 $11,007 - $21,673	832 Added 3.34%	25,714 $359,000
Q3 2021 Nov 12, 2021	BUY	$25.87 - $46.61 $643,697 - $1.16 Million	24,882 New	24,882 $644,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.